The Pediatric Dermatologist's View of Pediatric Vitiligo

Mark Weingarten, Michelle Schwartz, Candrice Heath, Nanette B. Silverberg

Research output: Contribution to journalArticlepeer-review


Background: No guidelines exist for pediatric vitiligo. Objective: To identify practice patterns of pediatric dermatologists treating vitiligo. Methods: A PeDRA survey was completed online by 56 pediatric dermatologists. Results: Practitioners reported feeling most comfortable treating 13 to 17 years old and least comfortable treating infants. Quality of life was assessed by interview in 89.3%. Topical calcineurin inhibitors (TCI), topical corticosteroids (TCS), Narrowband UVB, coverup makeup, topical JAK inhibitors (tJAKi), and 308-nm laser were the leading vitiligo therapeutics chosen. 94.5% of practitioners reported experiencing frustration due to difficulties procuring therapies. Conclusions: Pediatric vitiligo has notable effects on quality of life. Some therapeutic options exist which are preferred by pediatric dermatologists. There is a need for more data on therapeutics in infants and young children.

Original languageEnglish
Pages (from-to)E77-E78
JournalJournal of Drugs in Dermatology
Issue number2
StatePublished - Feb 2024


Dive into the research topics of 'The Pediatric Dermatologist's View of Pediatric Vitiligo'. Together they form a unique fingerprint.

Cite this